CN1739592A - Externally applied medicine for treating toothache - Google Patents

Externally applied medicine for treating toothache Download PDF

Info

Publication number
CN1739592A
CN1739592A CNA2004100203816A CN200410020381A CN1739592A CN 1739592 A CN1739592 A CN 1739592A CN A2004100203816 A CNA2004100203816 A CN A2004100203816A CN 200410020381 A CN200410020381 A CN 200410020381A CN 1739592 A CN1739592 A CN 1739592A
Authority
CN
China
Prior art keywords
toothache
weight portions
liniment
parts
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2004100203816A
Other languages
Chinese (zh)
Other versions
CN100500167C (en
Inventor
王宗其
王计民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2004100203816A priority Critical patent/CN100500167C/en
Publication of CN1739592A publication Critical patent/CN1739592A/en
Application granted granted Critical
Publication of CN100500167C publication Critical patent/CN100500167C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The externally applied medicine for treating toothache is prepared with the materials, including asarum herb 0.5-1 weight portions, borneol 10-20 weight portions, realgar 10-20 weight portions, pig bile 0.5-1 weight portions and gorgonian 10-20 weight portions and through drying, crushing, sieving, and mixing. The present invention may be used in treating various kinds of acute toothache, and has the features of fast acting, high curative effect, no recurrence, no toxic side effect, etc.

Description

A kind of liniment for the treatment of toothache
Affiliated field:
The present invention relates to a kind of medicine for the treatment of the tooth common disease, the particularly a kind of liniment that can treat toothache fast.
Background technology:
Odontopathy is a pilosity and easy repeatedly commonly encountered diseases, and its kind is a lot of as pulpitis, periodontitis, dental abscess, dental caries etc., and these odontopathy can both cause dental nerve pain, make the patient be difficult to stand.Modern medicine and motherland's traditional medicine provide multiple medicine, and decoction decoction pieces for oral administration is arranged, the mouth collutory of external, spray, powder etc.There is following defective in these medicines: 1, analgesic time is short; 2, can not effect a radical cure at short notice; 3, relapse rate height; 4, use trouble, and side effect is in various degree arranged.
Summary of the invention:
Purpose of the present invention just is to provide a kind of liniment for the treatment of toothache, this Chinese medicine can be used for happening suddenly emergence therapeutic of toothache, it have carry, easy to use, onset characteristics rapidly.
Technical scheme of the present invention is: a kind of liniment for the treatment of toothache is characterized in that: be the medicament that mixes, stirs and make by behind following raw materials according (consumption is a weight portion) drying, the crushing screening: wherein Herba Asari is that 0.5-1 part, Borneolum Syntheticum are that 10-20 part, Realgar are that 10-20 part, Fel Sus domestica are that 10-30 part, ZnSO4.7H2O are 10-30 part.
The best proportioning of raw material of the present invention is: 0.5 part of Herba Asari, 15 parts of Borneolum Syntheticums, 15 parts of Realgars, 20 parts of Fel Sus domestica, 20 parts of ZnSO4.7H2O.
Above-mentioned said medicament can be a said dosage form on any pharmaceutics, as powder.
Prescription of the present invention is according to being: but the Herba Asari wind-expelling pain-stopping is used for the treatment of toothache due to pathogenic wind-cold, gingiva is swollen mashed.Borneolum Syntheticum has clearing away heat to alleviate pain, sensible effect.But Realgar heat-clearing and toxic substances removing.Fel Sus domestica can be used for treating furuncle and dislikes swollen, conjunctival congestion and swelling pain.ZnSO4.7H2O has the dispel effect of pain, phagedenoma putrefaction removing of the stasis of blood clearly, and it is broken to can be used for treating toxic swelling, bulbar conjunctiva polyp pain.Therefore the present invention has heat clearing away, diffusing wind, antiinflammatory, detoxifcation, sensible, analgesic effect.
Advantage of the present invention is: 1, the present invention is directed to acute toothache that multiple reason causes and have treatment and open and imitate fast, analgesic effect rapidly, and can not recur after curing.Through clinical verification for many years, curative effect can reach 100%.2, the present invention does not contain any anesthetics, and is without any side effects.3, carry, easy to use.
Clinical observation report of the present invention:
Clinical data: this group case selects 235 examples to carry out clinical observation altogether.Dental caries 140 examples wherein, periodontitis 15 examples, dentin hypersensitiveness's 80 examples.
Therapeutic Method: according to the character and the clinical examination diagnosis of patient's odontopathy, the medicament that will be wrapped in immediately in the gauze spreads on the affected part, observes after 30 minutes, with the evaluation curative effect.
Curative effect determinate standard (single administration): significant curative effect: transference cure, painless; Basic curative effect: the sx of toothache can be stood; Invalid: medication is repeatedly all invalid, and symptom is not alleviated.
The example number Significant curative effect Basic curative effect Invalid
Dental caries 140 120 20 0
Periodontitis 15 10 5 0
Dentin hypersensitiveness 80 70 10 0
Curative effect of the present invention (showing as subordinate list): use medicament a drug of the present invention to obtain significant curative effect: dental caries accounts for 86%, periodontitis accounts for 67%, dentin hypersensitiveness accounts for 87.5%; Obtain basic curative effect: dental caries accounts for 14%, periodontitis accounts for 33%, dentin hypersensitiveness accounts for 12.5%.There is not invalid case.If obtain patient's administration for the second time of basic curative effect, can obtain significant curative effect.Total effective rate of the present invention can reach 100%.
The specific embodiment:
Take by weighing raw material according to following proportioning: 20 kilograms of 0.5 kilogram of Herba Asari, 15 kilograms of Borneolum Syntheticums, 15 kilograms of Realgars, 20 kilograms of Fel Sus domestica and ZnSO4.7H2O.
Production method is as follows: with after each selected component drying, the pulverizing, carry out the square-bottomed bamboo basket sieve respectively, with each component mix homogeneously, pack, get final product.

Claims (4)

1, a kind of liniment for the treatment of toothache is characterized in that: be the medicament that mixes, stirs and make by behind following raw materials according (consumption is a weight portion) drying, the crushing screening: wherein Herba Asari is that 0.5-1 part, Borneolum Syntheticum are that 10-20 part, Realgar are that 10-20 part, Fel Sus domestica are that 10-30 part, ZnSO4.7H2O are 10-30 part.
2, the liniment of treatment toothache according to claim 1, it is characterized in that: the best proportioning of above-mentioned each raw material is: 0.5 part of Herba Asari, 15 parts of Borneolum Syntheticums, 15 parts of Realgars, 20 parts of Fel Sus domestica, 20 parts of ZnSO4.7H2O.
3, the liniment of treatment toothache according to claim 1 and 2, it is characterized in that: above-mentioned said medicament can be a said dosage form on any pharmaceutics.
4, the liniment of treatment toothache according to claim 3, it is characterized in that: above-mentioned said medicament is a powder.
CNB2004100203816A 2004-08-27 2004-08-27 Externally applied medicine for treating toothache Expired - Fee Related CN100500167C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100203816A CN100500167C (en) 2004-08-27 2004-08-27 Externally applied medicine for treating toothache

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100203816A CN100500167C (en) 2004-08-27 2004-08-27 Externally applied medicine for treating toothache

Publications (2)

Publication Number Publication Date
CN1739592A true CN1739592A (en) 2006-03-01
CN100500167C CN100500167C (en) 2009-06-17

Family

ID=36092217

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100203816A Expired - Fee Related CN100500167C (en) 2004-08-27 2004-08-27 Externally applied medicine for treating toothache

Country Status (1)

Country Link
CN (1) CN100500167C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113456686A (en) * 2020-03-31 2021-10-01 林松洲 Medicine for treating decayed tooth

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113456686A (en) * 2020-03-31 2021-10-01 林松洲 Medicine for treating decayed tooth

Also Published As

Publication number Publication date
CN100500167C (en) 2009-06-17

Similar Documents

Publication Publication Date Title
CN1923244A (en) Pharmaceutical composition for treating skin diseases and preparation method and application thereof
CN1318071C (en) Chinese medicine preparation for treating bronchitis
CN100418570C (en) Medicine for treating female mazoplasia and preparation thereof
CN100500167C (en) Externally applied medicine for treating toothache
CN1895401A (en) Preparation of kidney-tonifying health-care tablet by micropowder technology
CN1044091C (en) Chinese-medicinal capsule for treatment of psoriasis
CN101249231B (en) Medicine composition for treating lithiasis and preparation thereof
CN1054762C (en) Medicine for treatment of epilepsy
CN1712055A (en) Chinese medicinal preparation (litholytic capsule) for treating urinific calculus
CN102784300A (en) Medicine composition for treating toothache and preparation method thereof
CN102335416A (en) Compound Chinese medicinal composition for treating hog cholera and preparation method thereof
CN1218708C (en) Chinese medicine prescription for curing eye disease and its preparation method
CN1251755C (en) Ointment for dispersing breast nodules and preparation method thereof
CN1850248A (en) Chinese medicine capsule for treating hyperplasia mammary glands and preparing method
CN100375633C (en) Psychotria serpens total sterol and its medicinal composition and use
CN1582989A (en) Medicine for hyperplasia of mammary glands and its preparation
CN1292776C (en) Medicine for treating facial hemiparalysis disease
CN1292285A (en) Medicine for curing diabetes
CN1745802A (en) Plaster for treating pain and prpearation thereof
CN1060670C (en) Spur medicinal powder and preparing method thereof
CN1682856A (en) Medicine composition for treating skin itching and senile skin itching and its preparing method
CN1065755C (en) Chinese compound medicine for treatment of hepatic calculus and cholecystitis
CN1057466C (en) Capsule for improving blood circulation and reducing fat
CN100563679C (en) The medicine of treatment hepatitis B great three positive, small three positive hepatopathy
CN1287829C (en) Shenjin pill for treating hyperplastic osteoarthritis and rheumatism and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090617

Termination date: 20120827